EU GDP Guidelines Explained | GxP Conversations Podcast Episode 23

How do medicines stay under control during storage, transport and distribution? GxP Conversations Episode 23 explores the EU Good Distribution Practice guidelines for medicinal products for human use. Need support with your own facility or quality system? Ask about GDP consultancy. W2 Cleanroom Consulting: https://www.w2cleanrooms.com The conversation follows the quality system behind a reliable pharmaceutical supply chain. It covers the Responsible Person, trained staff, suitable premises and equipment, and the records needed to show what happened to a product throughout its journey. We discuss: - Storage conditions and transport controls. - Supplier assurance and oversight of outsourced activities. - Complaints, returns, recalls and suspected falsified medicines. - Documentation, training and the role of brokers. These activities need to work together. A sound transport arrangement can still be undermined by unclear responsibilities, poor records or an uncontrolled return to stock. The episode explains the purpose of the controls and their place within GDP, rather than providing a site-specific distribution procedure. The discussion concerns the EU GDP guideline for human medicines. For the UK licensing and broker-registration context, continue with Episode 24 on MHRA Guidance Note 6. #GDP #GoodDistributionPractice #MedicinesDistribution Help Me GxP: www.helpmegmp.com Free GxP app: www.whatisgxp.com Help Me GxP is co-created and run by Kyle Winn and Adam Walker, who are also directors of W2 Cleanroom Consulting. W2 sponsors the channel. This video is for education. Use it alongside current guidance, your approved procedures and formal training.